Artigo Original
Costa et al
Insuficiência cardíaca chagásica grave
Arq Bras Cardiol. 2017; 108(3):246-254
6. Nunes MP, Colosimo EA, Reis RC, Barbosa MM, da Silva JP, Barbosa F, et
al. Different prognostic impact of the tissue Doppler-derived E/e’ ratio on
mortality in Chagas cardiomyopathy patients with heart failure. J Heart
Lung Transplant. 2012;31(6):634-41.
7. Mady C, Cardoso RH, Barretto AC, da Luz PL, Bellotti G, Pileggi F. Survival
and predictors of survival in patients with congestive heart failure due to
Chagas’ cardiomyopathy. Circulation. 1994;90(6):3098-102.
8. Ministério da Saúde; Ministério de Ci ncia e Tecnologia (MCT). Protocolo
do estudo multic ntrico randomizado de terapia celular em cardiopatias
- EMRTCC Cardiopatia Chagásica. Brasília 2006; 1-16. [Acesso em 2013
Jan 24.]. Disponível em:
/
outras_chamadas/formulario/protocolocardiopatiachagasica.pdf
9. Ribeiro dos Santos R, Rassi S, Feitosa G, Greco OT, Rassi A Jr, da Cunha
AB, et al; Chagas Arm of the MiHeart Study Investigators. Cell therapy
in Chagas cardiomyopathy (Chagas arm of the multicenter randomized
trial of cell therapy in cardiopathies study): a multicenter randomized
trial. Circulation. 2012;125(20):2454-61.
10. Sociedade Brasileira de Cardiologia; Sociedade Brasileira de
Hipertensão; Sociedade Brasileira de Nefrologia. [VI Brazilian Guidelines
on Hypertension]. Arq Bras Cardiol. 2010;95(1 Suppl):1-51. Erratum in:
Arq Bras Cardiol. 2010;95(4):553.
11. São Paulo. Hospital das Clínicas. FMUSP. Laboratório de análises clínicas.
Intervalo de refer ncia. Goiânia; 2015. [Acesso em 2015 set. 12.].
Disponível em
-
de-exames
12. Simões LA, Dias JM, Marinho KC, Pinto CL, Britto RR. Relationship
between functional capacity assessed by walking test and respiratory
and lower limb muscle function in community-dwelling elders. Rev Bras
Fisioter. 2010;14(1):24-30.
13. Brito RR, Sousa LA. Six minute walk test: a Brazilian standardization.
Fisioter mov. 2006;19(4):49-54.
14. Effect of enalapril on survival in patients with reduced left ventricular
ejection fraction and congestive heart failure. The SOLVD Investigators.
N Engl J Med. 1991;325(5):293-302.
15. CarvalhoFilhoHA,SousaAS,HolandaMT,HaffnerPM,AtiéJ,AmericanodoBrasil
PE,etal.Independentprognosticvalueofnonsustainedventriculartachycardiain
thechronicphaseofChagas’disease.RevSOCERJ.2007;20(6):395-405.
16. Garcia MI, Sousa AS, Holanda MT, Haffner PM, Americano do Brasil PE,
Hasslocher-MorenoA,etal.PrognosticvalueofQRSwidthinpatientswithchronic
Chagascardiomyopathy.RevSOCERJ.2008;1(1):8-20.
17. Lang RM, Badano LP, Mor-Avi V, Armstrong A, Ernande L, Flachskampf FA, et al.
Recommendations for cardiac chamber quantification by echocardiography
in adults: an update from the American Society of Echocardiography and the
EuropeanAssociationofCardiovascularImaging.EurHeartJCardiovascImaging.
2015;16(3):233-70.Erratumin:EurHeartJCardiovascImaging.2016;17(9):969;
EurHeartJCardiovascImaging.2016;17(4):412.
18. TheodoropoulosTA,BestettiRB,OtavianoA,CordeiroJA,RodriguesVC,SilvaAC.
Predictorsofall-causemortalityinchronicChagas’heartdiseaseinthecurrentera
ofheartfailuretherapy.IntJCardiol.2008;128(1):22-9.
19. Rassi S, Barretto AC, Porto CC, Pereira CR, Calaça BW, Rassi DC. [Survival and
prognostic factors in systolic heart failure with recent symptomonset]. Arq Bras
Cardiol.2005;84(4):309-13.
20. Rassi Ddo C, Vieira ML, Arruda AL, Hotta VT, Furtado RG, Rassi DT, et al.
Echocardiographic parameters and survival in Chagas heart disease with severe
systolicdysfunction.ArqBrasCardiol.2014;102(3):245-52.
21. Jorge AJ, Ribeiro ML, Rosa ML, Licio FV, Fernandes LC, Lanzieri PG, et al. Left
atriummeasurementinpatientssuspectedofhavingheartfailurewithpreserved
ejectionfraction.ArqBrasCardiol.2012;98(2):175-81.
22. NunesMC,BarbosaMM,RibeiroAL,ColosimoEA,RochaMO.Leftatrialvolume
providesindependentprognosticvalueinpatientswithChagascardiomyopathy.
JAmSocEchocardiogr.2009;22(1):82-8.
23. Rassi A Jr, Rassi A, LittleWC, Xavier SS, Rassi SG, Rassi AG, et al. Development
andvalidationofariskscoreforpredictiondeath inChagasheartdisease.NEngl
JMed.2006;355(8):799-808.
24. Ayub-FerreiraSM,ManginiS,IssaVS,CruzFD,BacalF,GuimarãesGV,etal.Mode
ofdeathonChagasheartdisease:comparisonwithotheretiologies:asubanalysis
oftheREMADHEprospectivetrial.PLoSNeglTropDis.2013;7(4):e2176.
254
